Understanding structural shifts in the market can help pharma stakeholders innovate and, ultimately, deliver benefits for patients
Change in the Japanese pharmaceutical market: Cradle of innovation or grave of corporate profits?
Published
Understanding structural shifts in the market can help pharma stakeholders innovate and, ultimately, deliver benefits for patients